Cancer

Personalized cancer treatment has been empowering patients to fight cancer and live longer.

By artfully combining the most innovative developments in genetic testing, immunotherapy, functional medicine and biological medicine, our Swiss Cancer Protocol delivers personalized cancer care to patients from all over the world.

Conventional cancer treatments use a “brute force” approach, with most patients getting the same treatment, be it radiation, chemotherapy, or drugs.

Contrary to the conventional approach, personalized cancer care uses tumor marker testing and custom tailors a treatment to each patient.

CLAVI-Q-RE for Cancer:

CLAVIC-Q-RE is best described as an Autologous Adoptive Cellular Therapy. It consists of the basic players of innate and adaptive immunity, i.e., macrophages and Natural Killer cells (innate immune cells) and activated Dendritic Cells, T cells and antibody producing plasma cells (adaptive immune cells). Innate immune cells are ready to fight any pathogen or cancer cell in an antigen independent manner, while T cells and B cells require pre- activation with antigenic peptides. Activation of adaptive immune cells is performed with dendritic cells, a type of antigen presenting cells (APC). All these cells are generated from a patient’s blood and then be infused back to the patient.